Merck & Co already planning for a post-Keytruda world - The Pharma Letter

Merck & Co already planning for a post-Keytruda world  The Pharma Letter

At its first investor day in five years, New Jersey, USA-based Merck & Co (NYSE: MRK) outlined key aspects of its clinical and commercial strategy, with chief e.



Comments

Popular posts from this blog

Глушители. Приборы бесшумной стрельбы